Harmony Biosciences Holdings annual depreciation and amortization
2019
2020
2021
2022
2023
2024
2025
Harmony Biosciences Holdings Depreciation & Amortization Growth & History (HRMY)
Harmony Biosciences Holdings's depreciation and amortization was $25.3M for fiscal 2025.
View full Harmony Biosciences Holdings company overviewHarmony Biosciences Holdings annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $25.3M | $1.2M | +5.07% |
| 2024 | 2024-12-31 | $24.1M | −$247,000 | −1.01% |
| 2023 | 2023-12-31 | $24.4M | $974,000 | +4.17% |
| 2022 | 2022-12-31 | $23.4M | $4.5M | +24.12% |
| 2021 | 2021-12-31 | $18.8M | $8.6M | +84.04% |
| 2020 | 2020-12-31 | $10.2M | $7.0M | +218.91% |
| 2019 | 2019-12-31 | $3.2M | — | — |
Harmony Biosciences Holdings quarterly depreciation and amortization
Q1.20
Q2.20
Q3.20
Q1.21
Q2.21
Q3.21
Q1.22
Q2.22
Q3.22
Q1.23
Q2.23
Q3.23
Q1.24
Q2.24
Q3.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $6.0M | $1,000 | +0.02% |
| Q1 2026 | 2026-03-31 | $6.0M | $0 | 0.00% |
| Q4 2025 | 2025-12-31 | $7.4M | — | — |
| Q3 2025 | 2025-09-30 | $6.0M | $0 | 0.00% |
| Q2 2025 | 2025-06-30 | $6.0M | −$85,000 | −1.40% |
| Q1 2025 | 2025-03-31 | $6.0M | −$156,000 | −2.55% |
| Q3 2024 | 2024-09-30 | $6.0M | −$138,000 | −2.26% |
| Q2 2024 | 2024-06-30 | $6.1M | −$12,000 | −0.20% |
| Q1 2024 | 2024-03-31 | $6.1M | $60,000 | +0.99% |
| Q3 2023 | 2023-09-30 | $6.1M | $44,000 | +0.73% |
| Q2 2023 | 2023-06-30 | $6.1M | $9,000 | +0.15% |
| Q1 2023 | 2023-03-31 | $6.1M | $865,000 | +16.64% |
| Q3 2022 | 2022-09-30 | $6.1M | $1.4M | +29.75% |
| Q2 2022 | 2022-06-30 | $6.1M | $1.3M | +28.04% |
| Q1 2022 | 2022-03-31 | $5.2M | $520,000 | +11.11% |
| Q3 2021 | 2021-09-30 | $4.7M | $2.7M | +137.52% |
| Q2 2021 | 2021-06-30 | $4.7M | $2.7M | +135.98% |
| Q1 2021 | 2021-03-31 | $4.7M | $2.8M | +148.49% |
| Q3 2020 | 2020-09-30 | $2.0M | — | — |
| Q2 2020 | 2020-06-30 | $2.0M | — | — |
| Q1 2020 | 2020-03-31 | $1.9M | — | — |
Harmony Biosciences Holdings depreciation and amortization trends
Over the last five fiscal years, Harmony Biosciences Holdings's depreciation and amortization increased from $10.2M to $25.3M, a change of $15.1M. The latest reported quarter, Q2 2026, shows $6.0M.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Harmony Biosciences Holdings source filings ↗